Skip to content
Home / Media Hub / News and Press / Our Sustainability Journey Video Series Part Two: Reporting

Our Sustainability Journey Video Series Part Two: Reporting

Corden Connect Newsletter
17 Mar 26
André Durrer, Head of Global Compliance Management Systems, CordenPharma International


Why is CordenPharma reporting about its sustainability program?

Providing transparency on our sustainability strategy, objectives, and performance is important for CordenPharma and its owner, Astorg.

That’s why we have recently published our first sustainability report and will keep on disclosing regular updates to all stakeholders.

Which other sustainability related disclosures is CordenPharma supporting?

We are part of several initiatives, such as the UN Global Compact, the Science Based Targets initiative (SBTi), and CDP (formerly Carbon Disclosure Project).

Reporting under these initiatives reflects our commitment to transparency, and strengthens the relationships with our customers.

What is covered in the first sustainability report?

The report contains:

  • an overview about the CordenPharma group,
  • our progress and performance against our sustainability targets,
  • our technical innovations, such as TAPS (Tag-Assisted Peptide Synthesis), and
  • our achievements and recognitions, like management systems certifications, CDP score, and EcoVadis results.

We are demonstrating both commitment and progress, while maintaining a strong ethical framework. I encourage you to read our first sustainability report.

Want to find out more?

Get in touch with our team of experts to explore bespoke end-to-end CDMO support of your complete drug lifecycle
at any scale.